image
Healthcare - Biotechnology - NASDAQ - US
$ 0.9605
0.541 %
$ 76.9 M
Market Cap
2.54
P/E
INCOME STATEMENT
138 M REVENUE
36.45%
25 M OPERATING INCOME
485.49%
31.9 M NET INCOME
5700.88%
EFFICIENCY
Earnings Waterfall CytomX Therapeutics, Inc.
image
Revenue 138 M
Cost Of Revenue 1.77 M
Gross Profit 136 M
Operating Expenses 113 M
Operating Income 25 M
Other Expenses -6.87 M
Net Income 31.9 M
140m140m120m120m100m100m80m80m60m60m40m40m20m20m00138m(2m)136m(113m)25m7m32mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 138.1 101.2 53.2 69.6 100.4 57.5 59.5 71.6 15.0 7.7 5.1 0.9
GROSS PROFIT
Cost Of Revenue 1.8 0 5.9 5.8 0 0 0 0 0 0 0 0
Gross Profit 136.3 101.2 47.3 63.7 100.4 57.5 59.5 71.6 15.0 7.7 5.1 0.9
OPERATING INCOME
Operating Expenses 113.1 107.7 154.5 153.4 149.0 168.4 137.4 117.9 74.6 40.9 34.8 15.8
Selling, General and Administrative Expenses 29.7 30.0 42.8 39.2 36.0 36.8 33.5 25.6 19.9 12.6 6.5 5.0
Research and Development Expenses 83.4 77.7 111.6 114.2 112.9 131.6 103.9 92.3 54.8 28.4 28.3 10.9
Operating Income 25.0 (6.5) (101.3) (83.8) (48.6) (110.9) (77.9) (46.3) (59.6) (33.2) (29.8) (15.0)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0 0 1.7 1.7 0.5 0.3
Total Other Income 7.1 9.8 2.0 0.2 1.8 8.2 7.6 2.6 0.7 (2.2) (0.5) (0.2)
Pre-Tax Income 32.1 3.3 (99.3) (83.6) (46.8) (102.7) (70.3) (43.6) (58.9) (35.4) (30.3) (15.1)
NET INCOME
Tax Provision 0.2 3.9 (2.0) (3.0) (13.9) (0.4) 14.3 (0.5) 19 K 10 K 10 K 10 K
Net Income 31.9 (0.6) (97.3) (80.6) (32.9) (102.2) (84.6) (43.1) (58.9) (35.4) (30.3) (15.1)
EPS 0.38 0.0077 1.48 1.26 0.71 2.26 2.03 1.16 1.63 4.12 0.87 0.43